SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties

Affiliations

• ¹ Université Paris Dauphine-PSL, Paris, France; Esade Centre for Economic Policy, Barcelona, Spain.
• ² French National Centre of Scientific Research (CNRS), CS 40700, 38058 Grenoble cedex 9, France; Oxford-Man Institute of Quantitative Finance, University of Oxford, Oxford, UK. Electronic address: bary.pradelski@cnrs.fr.
• ³ Collège de France, Paris, France; London School of Economics and Political Science, London, UK; INSEAD, Fontainebleau, France.
• ⁴ Natixis, Paris, France; Paris School of Economics, Paris, France.
• ⁵ Global Health Centre, Graduate Institute of International and Development Studies, Geneva, Switzerland.
• ⁶ Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain.
• ⁷ Global Health Governance Programme, Usher Institute of Population Health Sciences and Informatics and College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK.
• ⁸ Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Oxford, UK.